Leukotriene Pathway Activation Associates with Poor Glycemic Control and with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes

<div>Expression of <i>LTB4R</i> mRNA in peripheral blood mononuclear cells (a) and plasma concentrations of leukotriene B4 (b) in type 1 diabetes individuals sorted by the use of angiotensin-converting enzyme inhibitor (ACEI) (adjusted for sex, age, HbA<sub>1</sub>C, diabetes duration, and use of angiotensin receptor blocker and statin).</div>

Mediators of Inflammation

fig5

Figure 5

Figure 5: Leukotriene Pathway Activation Associates with Poor Glycemic Control and with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes 